The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

Complex, chronic illness experts discuss what GLP-1 agonists can and can't do in diseases like ME/CFS, long COVID, and POTS. Plus new long COVID trials.
The “Septad” – a Treatment Roadmap for ME/CFS, POTS, Long COVID : From “Unraveled” a Patreon Broadcast from Dr. Kaufman and Ruhoy

The “Septad” – a Treatment Roadmap for ME/CFS, POTS, Long COVID : From “Unraveled” a Patreon Broadcast from Dr. Kaufman and Ruhoy

Two doctors discuss the seven distinguishing factors that tie diseases like chronic fatigue syndrome, fibromyalgia, POTS, long COVID, joint hypermobility syndrome together.
Damaged Small Nerve Fibers May be Causing Energy Problems in Chronic Fatigue Syndrome (ME/CFS)

Damaged Small Nerve Fibers May be Causing Energy Problems in Chronic Fatigue Syndrome (ME/CFS)

Invasive exercise study uncovers two different kinds of chronic fatigue syndrome. One is characterized by low heart outputs associated with reduced preload and blood pooling. The other is probably caused by shunts which propel blood away from the muscles. Approximately 30% of ME/CFS patients have small fiber neuropathy as well. Deconditioning is not causing the abnormalities found.
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest